Eli Lilly (NYSE:LLY) has decided to end its partnership with CVS Health (NYSE:CVS) as the pharmacy benefits provider for its U.S. employees, following CVS’s decision to drop coverage of Lilly’s weight ...
Eli Lilly (LLY) is exiting CVS Health’s (CVS) drug benefit plan for its employees after the managed care giant decided to limit access to the company’s popular weight loss drug, Zepbound, in favor of ...
Also Read: Eli Lilly's Investigational Obesity Drug Shows Up To 20% Weight Loss In Phase 2 Study, Analyst Sees It As Emerging Cornerstone In Obesity Treatment In March, Novo Nordisk launched NovoCare ...
CVS Health's Caremark business signed a new pharmacy benefits contract with the California Public Employees' Retirement System, known as Calpers. The five-year contract provides outpatient drug ...
CVS Health's Caremark business signed a new pharmacy benefits contract with the California Public Employees' Retirement System, known as Calpers. The five-year contract includes new financial terms ...